On the occasion of World Haemophilia Day on Friday, the Manipal Chapter of Haemophilia Society will organise a summer camp for patients suffering from the disorder at Bharathiya Vikas Trust here from Friday to Sunday.
Hemophilia is a group of hereditary genetic disorders that impair the body’s ability to control blood clotting.
There are two types of hemophilia. Haemophilia A occurs in about 1 out of every 5000 live male births.
Dr.Azzam Alzoebie, Chiefof Pediatric Oncology and Haematology Division at SKMC, certified by the American Board of Pediatrics and the American Board of Pediatric Hematology & Oncology, stated: “Haemophilia affects many aspects of a person’s health and daily life.The paediatric haematology & Oncology division has initiated a factor VIII prophylaxis program for severe Haemophilia A patients to receive their missing clotting factor three times a week”.
The body protects itself from bleeding by producing sticky blood cells called platelets.In people without haemophilia these sticky cells plug any cuts or grazes and then release chemicals that activate biological molecules in the body, which enable the blood to form a clot.
Though Haemophilia is an inherited condition in the majority, in 30 per cent of the cases it is caused by a change in the genes called spontaneous mutation.In other words, a patient with excessive bleeding needs to be evaluated for Haemophilia and clotting factor deficiency, even though there is no family history.An female with a family history of Haemophilia and who is pregnant or intending to conceive should consult a doctor for genetic testing and exclusion of occurrence of Haemophilia in the fetus.
Hemophilia A is the most common form of the disorder, present in about 1 in 5,000-10,000 male births.
Dr. Abdelmajeed Al Zubaidi, Chief Medical Officer at SKMC, certified with the American Board of Internal Medicine said, “We welcome such public awareness campaigns as these annual events create an informative and engaging environment in which information and expert support is easily accessible to families”.
Haemophilia A is a recessive X-linked genetic disorder involving a lack of functional clotting Factor VIII.
In someone with haemophilia one of the clotting factors required for the blood to clot properly is missing.
Each type of Haemophilia causes prolonged bleeding which is the main symptom of hemophilia.
Currently, SKMC cares forapproximately56 children with haemophilia and congenital bleeding disorders and another 22 adults.
Haemophilia can affect people of any race or nationality and is termed mild, moderate or severe, depending on the level of clotting factor in the blood.
For replacement therapy, the clotting factor concentrates can be derived from either human donor blood or can be synthetically made in the laboratory using methods that do not use donor blood.
“Purple Soupa team from Australia will be conducting the activities at the camp which is being partly funded by Novo Nordisk Haemophilia Foundation, ” said Annamma Kurien, Associate Dean of Melaka Manipal Medical College, Manipal University.